Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avisa Pharma Inc.
DescriptionPoint-of-care breath test to detect bacterial infections by the conversion of the company's proprietary substrate AV-U13
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect tuberculosis (TB)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today